{
    "id": 6211,
    "name": "mixed epithelial tumor of ovary",
    "source": "DOID",
    "definition": "An ovarian benign neoplasm that is biphasic and has_material_basis_in epithelial and mesenchymal elements. [url:https\\://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957347/]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:6211",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT04034927",
            "title": "Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 837,
                    "therapyName": "Olaparib",
                    "synonyms": null
                },
                {
                    "id": 8289,
                    "therapyName": "Olaparib + Tremelimumab",
                    "synonyms": null
                }
            ]
        }
    ]
}